Aldeyra Therapeutics Inc
(NAS:ALDX)
$
3.2
-0.05 (-1.54%)
Market Cap: 190.13 Mil
Enterprise Value: 72.75 Mil
PE Ratio: 0
PB Ratio: 1.68
GF Score: 40/100 Aldeyra Therapeutics Inc (ALDX) Transcripts
- Aldeyra Therapeutics Inc ADX-629 Results Call TranscriptDec 19, 2023
- Aldeyra Therapeutics Inc Top-Line Results from the Phase 2 Clinical Trial of ADX-2191 Call TranscriptJun 29, 2023
- Aldeyra Therapeutics Inc Top-Line Results from the Phase 2 Clinical Trial of ADX-629 in Patients with Chronic Cough Call TranscriptJun 27, 2023
- Aldeyra Therapeutics Inc Top-Line Results from the Phase 3 INVIGORATE-2 Trial in Allergic Conjunctivitis Call TranscriptJun 15, 2023
- Aldeyra Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Q4 2022 Aldeyra Therapeutics Inc Earnings Call TranscriptMar 09, 2023$7.9 (+7.19%)Earnings
- Q3 2022 Aldeyra Therapeutics Inc Earnings Call TranscriptNov 10, 2022$5.5 (+6.18%)Earnings
- Aldeyra Therapeutics Inc to Announce Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy Call TranscriptOct 06, 2022
- Q2 2022 Aldeyra Therapeutics Inc Earnings Call TranscriptAug 05, 2022$6.92 (+10.90%)Earnings
- Aldeyra Therapeutics Inc Call to Report Top-Line Results from the Crossover Clinical Trial of Reproxalap TranscriptJul 12, 2022
- Aldeyra Therapeutics Inc TRANQUILITY-2 Top-Line Data Results Call TranscriptJun 08, 2022
- Q1 2022 Aldeyra Therapeutics Inc Earnings Call TranscriptMay 05, 2022$2.78 (-5.12%)Earnings
- Aldeyra Therapeutics Inc Research & Development Day TranscriptMar 29, 2022
- Q4 2021 Aldeyra Therapeutics Inc Earnings Call TranscriptMar 17, 2022$4.86 (+16.27%)Earnings
- Aldeyra Therapeutics Inc Conference Call and Webcast TranscriptDec 20, 2021
- Q3 2021 Aldeyra Therapeutics Inc Earnings Call TranscriptOct 28, 2021$9 (+9.22%)Earnings
- Aldeyra Therapeutics Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Aldeyra Therapeutics Inc Earnings Call TranscriptAug 05, 2021$9.57 (+8.26%)Earnings
- Q1 2021 Aldeyra Therapeutics Inc Earnings Call TranscriptMay 06, 2021$12.05 (+0.67%)Earnings
- Aldeyra Therapeutics Inc Provide Results from the Phase 3 Invigorate Clinical Trial Corporate Call TranscriptApr 27, 2021
- Q4 2020 Aldeyra Therapeutics Inc Earnings Call TranscriptMar 11, 2021$12.07 (-0.08%)Earnings
- Aldeyra Therapeutics, Inc. - Special Call TranscriptJan 07, 2021
- Q3 2020 Aldeyra Therapeutics Inc Earnings Call TranscriptNov 05, 2020$6.95 (+2.36%)Earnings
- Apellis Pharmaceuticals Inc, Aerie Pharmaceuticals, Aldeyra Therapeutics, and ProQR Therapeutic at Citi BioPharma Conference (Virtual) - Panel TranscriptSep 10, 2020
- Q2 2020 Aldeyra Therapeutics Inc Earnings Call TranscriptAug 06, 2020$6.76 (-9.38%)Earnings
- Aldeyra Therapeutics, Inc. - Special Call TranscriptMay 20, 2020
- Q1 2020 Aldeyra Therapeutics Inc Earnings Call TranscriptMay 07, 2020$2.83 (-3.41%)Earnings
- Q4 2019 Aldeyra Therapeutics Inc Earnings Call TranscriptMar 12, 2020$2.42 (-13.26%)Earnings
- Aldeyra Therapeutics Inc Corporate Analyst Meeting TranscriptFeb 24, 2020
- Aldeyra Therapeutics, Inc. - Special Call TranscriptDec 03, 2019
- Q3 2019 Aldeyra Therapeutics Inc Earnings Call TranscriptNov 07, 2019$5.76 (-4.48%)Earnings
- Aldeyra Therapeutics, Inc. - Special Call TranscriptOct 31, 2019
- Q2 2019 Aldeyra Therapeutics Inc Earnings Call TranscriptAug 08, 2019$5.4 (-0.74%)Earnings
- Aldeyra Therapeutics, Inc. - Special Call TranscriptJun 25, 2019
- Q1 2019 Aldeyra Therapeutics Inc Earnings Call TranscriptMay 09, 2019$8.03 (+0.63%)Earnings
- Aldeyra Therapeutics, Inc. - Special Call TranscriptMar 26, 2019
- Q4 2018 Aldeyra Therapeutics Inc Earnings Call TranscriptMar 08, 2019$7.53 (-3.71%)Earnings
- Aldeyra Therapeutics, Inc. - Special Call TranscriptFeb 28, 2019
- 1